Exclusive

Publication

Byline

Alfa Transformers cancels board meeting

Mumbai, April 15 -- Alfa Transformers has cancelled the board meeting which was scheduled to be held on 15 April 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More


New York Manufacturing Index Unexpectedly Indicates Growth In April

India, April 15 -- A report released by the Federal Reserve Bank of New York on Wednesday unexpectedly showed a moderate increase in New York manufacturing activity in the month of April. The New Yor... Read More


Morgan Stanley Stock Rises 4% On Strong Q1 Earnings Beat

India, April 15 -- Morgan Stanley (MS) shares climbed 4.22 percent to $191.07, gaining $7.73 on Wednesday, after the company reported strong first-quarter results driven by robust revenue growth and l... Read More


ASML Shares Down After Reporting Quarterly Results

India, April 15 -- Shares of ASML Holding N.V. (ASML) slipped nearly 4% on Wednesday morning after reporting first-quarter results, despite both profit and revenues rising from last year. The stock i... Read More


Sanghvi Movers appoints Saumil Dave as Chief Operating Officer

Mumbai, April 15 -- Sanghvi Movers announced that Saumil Dave has been appointed as the Chief Operating Officer (COO) of the Company and designated as Senior Management Personnel. Published by HT Dig... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More